European Journal of Cell BiologyCell BiologyPeer-reviewed journal article
The Kelch 3 motif on gigaxonin mediates the interaction with NUDCD3 and regulates vimentin filament morphology
Cassandra L. PhillipsiD, C.C. So, Meredith F. GillisiD, Jonathan Harrison, Chih-Hsuan HsuiD, Diane M. ArmaoiD, Natasha Tasheva SnideriD
- Citations
- 1
- FWCI
- 0.50
- Field percentile
- top 40%
Abstract
Gigaxonin is an intermediate filament (IF)-interacting partner belonging to the Kelch-like (KLHL) protein family. Gigaxonin is encoded by the KLHL16 gene, which is mutated in Giant Axonal Neuropathy (GAN). The lack of functional gigaxonin in GAN patient cells impairs IF proteostasis, leading to focal abnormal accumulations of IFs and compromised neuronal function. We hypothesized that gigaxonin forms molecular interactions via specific sequence motifs to regulate IF proteostasis. The goal of this study was to examine how distinct Kelch motifs on gigaxonin regulate IF protein degradation and filament morphology. We analyzed vimentin IFs in HEK293 cells overexpressing wild type (WT) gigaxonin, or gigaxonin lacking each of the six individual Kelch motifs: K1 (aa274-326), K2 (aa327-374), K3 (aa376-421), K4 (aa422-468), K5 (aa470-522), and K6 (aa528-574). All six gigaxonin deletion mutants ({Delta}K1-{Delta}K6) promoted the degradation of soluble vimentin. The {Delta}K3 gigaxonin mutant exhibited soluble vimentin degradation and promoted the bundling of vimentin IFs relative to WT gigaxonin. Using mass spectrometry proteomic analysis we found that, relative to WT gigaxonin, {Delta}K3 gigaxonin had increased associations with ubiquitination-associated and mitochondrial proteins and lost the association with the NudC domain-containing protein 3 (NUDCD3), a molecular chaperone enriched in the nervous system. Collectively, our cell biological data show the induction of an abnormal GAN-like IF phenotype in cells expressing {Delta}K3-gigaxonin, while our mass spectrometry profiling links the loss of gigaxonin-NUDCD3 interactions with defective IF proteostasis, revealing NUDCD3 as a potential new target in GAN.
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: protein folding & dynamics
- research focus: chromatin & epigenetic regulation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Gigaxonin is required for intermediate filament transport
B. Renganathan, J. P. Zewe, … V. I. Gelfand·bioRxiv·Aug 19, 2022
- Glycosylation of gigaxonin regulates intermediate filaments: Novel molecular insights into giant axonal neuropathy
P.-H. CHEN, T. Smith, … M. Boyce·bioRxiv·Jan 26, 2019
- Calpain-mediated proteolysis of vimentin filaments is augmented in Giant Axonal Neuropathy (GAN) fibroblasts exposed to hypotonic stress
C. L. Phillips, D. Fu, … N. Snider·bioRxiv·Jul 31, 2022
- Gigaxonin, mutated in Giant Axonal Neuropathy, interacts with TDP-43 and other RNA binding proteins
Cassandra L. Phillips, Maryam Faridounnia, … Natasha Tasheva Snider·bioRxiv·Sep 3, 2024
- Intermediate filament dysregulation and astrocytopathy in the human disease model of KLHL16 mutation in giant axonal neuropathy (GAN)
R. Battaglia, M. Faridounnia, … N. Snider·bioRxiv·Mar 13, 2023
- Neurofilament accumulation disrupts autophagy in giant axonal neuropathy
Jean‐Michel Paumier, James P. Zewe, … Puneet Opal·JCI InsightPeer-reviewed·Mar 9, 2025